118 related articles for article (PubMed ID: 38326205)
1. Sarcopenia Affects Liver Regeneration and Long-Term Survival Rate After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma.
Wu MY; Yeh CH; Liao CC; Chen CL; Wang CC; Lin CC; Chang WC; Cheng YF; Ou HY
Transplant Proc; 2024 Apr; 56(3):573-580. PubMed ID: 38326205
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia adversely impacts postoperative complications in living-donor liver transplantation recipients.
Wu MY; Lim WX; Cheng YF; Chang CD; Hsu HW; Lin CC; Chen CL; Chang WC; Yu CY; Tsang LL; Chuang YH; Ou HY
Sci Rep; 2021 Sep; 11(1):19247. PubMed ID: 34584142
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia defined by psoas muscle index independently predicts long-term survival after living donor liver transplantation in male recipients.
Tan Y; Duan T; Li B; Zhang B; Zhu Y; Yan K; Song J; Lv T; Yang J; Jiang L; Yang J; Wen T; Yan L
Quant Imaging Med Surg; 2022 Jan; 12(1):215-228. PubMed ID: 34993073
[TBL] [Abstract][Full Text] [Related]
4. Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation.
Chae MS; Moon KU; Jung JY; Choi HJ; Chung HS; Park CS; Lee J; Choi JH; Hong SH
Liver Transpl; 2018 May; 24(5):623-633. PubMed ID: 29365358
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM
Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
Kulik LM; Fisher RA; Rodrigo DR; Brown RS; Freise CE; Shaked A; Everhart JE; Everson GT; Hong JC; Hayashi PH; Berg CL; Lok AS;
Am J Transplant; 2012 Nov; 12(11):2997-3007. PubMed ID: 22994906
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
[TBL] [Abstract][Full Text] [Related]
8. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
[TBL] [Abstract][Full Text] [Related]
10. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
11. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
12. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X
Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095
[TBL] [Abstract][Full Text] [Related]
13. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation.
Li C; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Wei YG
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):366-9. PubMed ID: 20688599
[TBL] [Abstract][Full Text] [Related]
14. Serum Tumor Necrosis Factor-α Is Inversely Associated With the Psoas Muscle Index in Both Male and Female Patients Scheduled for Living Donor Liver Transplantation.
Shim JW; Yang S; Jung JY; Choi HJ; Chung HS; Hong SH; Park CS; Choi JH; Chae MS
Transplant Proc; 2019; 51(6):1874-1879. PubMed ID: 31262437
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant.
Lai Q; Sapisochin G; Gorgen A; Vitale A; Halazun KJ; Iesari S; Schaefer B; Bhangui P; Mennini G; Wong TCL; Uemoto S; Lin CC; Mittler J; Ikegami T; Yang Z; Frigo AC; Zheng SS; Soejima Y; Hoppe-Lotichius M; Chen CL; Kaido T; Lo CM; Rossi M; Soin AS; Finkenstedt A; Emond JC; Cillo U; Lerut JP
JAMA Surg; 2021 Sep; 156(9):e213112. PubMed ID: 34259797
[TBL] [Abstract][Full Text] [Related]
16. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
[TBL] [Abstract][Full Text] [Related]
17. Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.
Dai WC; Chan SC; Chok KS; Cheung TT; Sharr WW; Chan AC; Tsang SH; Fung JY; Poon RT; Fan ST; Lo CM
HPB (Oxford); 2014 Aug; 16(8):749-57. PubMed ID: 24467735
[TBL] [Abstract][Full Text] [Related]
18. Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison.
Wan P; Zhang JJ; Li QG; Xu N; Zhang M; Chen XS; Han LZ; Xia Q
World J Gastroenterol; 2014 Apr; 20(15):4393-400. PubMed ID: 24764678
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
[TBL] [Abstract][Full Text] [Related]
20. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
Cho Y; Lee JH; Lee DH; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS
Oncotarget; 2017 Jul; 8(29):47555-47564. PubMed ID: 28548930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
